Hypertension and nephrology - 2021;25(02)

Hypertension and nephrology

APRIL 29, 2021

[At the doorstep of an attitude change: our novel knowledge on renal fibrosis in chronic kidney disease]

BUKOSZA Nóra Éva

[In spite of the diverse etiology, chronic kidney disease is finally leading to end-stage renal disease uniformly by the fibrotic transformation of the kidneys. In recent years – mainly due to experimental data – the explanation of this transformation changed profoundly: it has been revealed, that renal fibrosis is a dynamic, actively ongoing process involving many keyfactors. Influencing these factors, give us hope to prevent the progression of chronic kidney disease. This review... tovább »

Hypertension and nephrology

APRIL 29, 2021

[When should antihypertensive be taken: in the morning and/or evening? Chronopharmacotherapy of hypertension in practice]

SZAUDER Ipoly

[The circadian (24-hour) variability of blood pressure (BP) is influenced by constant and variable (external and internal) factors. With this in mind and by determining the type of hypertension with a 24-hour blood pressure monitoring (ABPM), individual chronopharmacological (chronopharmacotherapy) treatment can be planned. There are significant differences in the chronokinetics of antihypertensive drugs administered at different times. Their therapeutic range and efficacy... tovább »

Hypertension and nephrology

APRIL 29, 2021

[Current evidence on the accuracy and precision of non-invasive cardiac output monitoring]

VÉGH Anna, REUSZ S György

[Purpose of review: Assessing cardiac output (CO) is an important part of monitoring the hemodynamically unstable patients. Different non-invasive CO measurement devices are currently available, that can be useful in various clinical situations. The purpose of this article is to review current literature on commonly employed methods especially regarding their accuracy and precision. Results: Most of the devices, especially the non-invasive ones have the disadvantage of questionable... tovább »

Hypertension and nephrology

APRIL 29, 2021

[Independent risk factors for fatal cases of the Covid-19 pandemic]

KÉKES Ede

[Already at the beginning of the Covid-19 pandemic, it was known to be severe and critical mortality rates (crude fatality rate (CFR) is a major and crucial factor in this age on the other hand, men have a higher incidence of fatalities. Another known fact is that comorbidities (coronary heart disease, hypertension, diabetes, COPD) are more common in severe or fatal cases. However, for these the causal role of diseases has not been clarified for a long time, then it turned out that the... tovább »

Hypertension and nephrology

APRIL 29, 2021

[Medical letters about Covid-19. II. part]

FARSANG Csaba

[In March 2020, the coronavirus epidemic reached Hungary as well, which had and has had a multifaceted effect on society as a whole, to the medical community and, to a greater extent, to patients. In the second letter, seek medical help, a I deal with the role and significance of patient symptoms, stress, and physical activity.]

Hypertension and nephrology

APRIL 29, 2021

Hypertension and nephrology

APRIL 29, 2021

[Primary aldosteronism, the mysterious object of desire – in the context of a study]

BAJNOK László

[The aldosterone-producing adenoma, aldosteronoma, the actual Conn syndrome, is a relatively well-defined entity, while the separability of idiopathic hyperaldosteronism and low-renin primary hypertension appears to be inherently uncertain according to our current knowledge. In this way, the diagnosis of primary aldosteronism (PA) is in fact more or less probabilistic and this also contributes fundamentally to the uncertainty of prevalence data. These are confirmed by a recent study in... tovább »

Hypertension and nephrology

APRIL 29, 2021

[A turning point in the approach to primary aldosteronism?]

ALFÖLDI Sándor

[In László Bajnok 's warning summary statement a secondary hypertension with the most common endocrine disease, the primary related to aldosteronism, recently published two important studies (1, 2) show that it is a paradigm shift began in the assessment of the disease, and so far professional guidelines (3, 4) have been questioned]

Hypertension and nephrology

APRIL 29, 2021

[Covid-19 and peripheral arterial disease]

FARKAS Katalin

[Patients with peripheral vascular disease (PAD) are negatively affected by the coronavirus epidemic in several ways. Fewer-than-usual doctor-patient encounters make it more difficult to detect disease or disease progression. Outbreaks due to the epidemic reinforce a sedentary lifestyle that can mask the symptoms of PAD through lack of exercise. Another risk is that patients with cardiovascular disease are at risk for severe Covid-19 disease, and have a significantly increased risk of... tovább »

Hypertension and nephrology

APRIL 29, 2021

[Case report of supine hypertension and extreme reverse dipping phenomenon decades after kidney transplantation]

BATTA Dóra, KŐRÖSI Zita Beáta, NEMCSIK János

[Supine hypertension, a consequence of autonomic neuropathy, is a rarely recognized pathological condition. Reported diseases in the background are pure autonomic failure, multiple system atrophy, Parkinson’s disease, diabetes and different autoimmune disorders. In our case report we present a case of supine hypertension which developed in a patient decades after kidney transplantation. The patient was followed for 25 months and we demonstrate the effect of the modification of... tovább »

Hypertension and nephrology

APRIL 29, 2021

[Pyelonephritis acuta]

[Primarily bacterial infections (E. coli, Proteus mirabilis, Klebsiella, Enterococcus), tubules, interstitium, acute inflammatory condition of the renal calves and pelvic pelvis. Most often as a result of ascending urinary tract infection less frequently due to haematogenic variance. Risk factors for the development of diabetes are immunosuppressive condition, obstructive in maintaining urinary retention uropathies (kidney stones, tumors, or congenital urotra or acquired dysfunction and... tovább »

Hypertension and nephrology

APRIL 29, 2021

[ACCREDITED CONTINUING TRAINING]

[Dear Reader! By completing the test, 20 accreditation points can be earned. Submit responses electronically (e-mail: hypnet21@gmail.com) by providing the data required for registration (name, place of work, medical stamp number). In the e-mail sent, after the registration data, the 21HNAT mark, the question number and the correct solution letter must be to indicate. Acceptance period: 1 April to 15 May 2021]